Calculation of your study is finished. Please find your results below.

A study for a 50 year old woman who takes Wellbutrin Xl, Topamax, Wellbutrin, Suboxone, Celebrex, Wegovy, Lexapro (an AI-powered real world drug study)

Summary:

18 females aged 50 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 50 year old female patient who has Generalised Anxiety Disorder, Migraine, Chronic Back Pain, Arthritis, Lose Weight, Major Depression. The study is created by eHealthMe based on reports from sources including the FDA.


On Aug, 01, 2026

18 females aged 50 (±5) who take Wellbutrin Xl, Topamax, Wellbutrin, Suboxone, Celebrex, Wegovy, Lexapro and have adverse effects are studied.


Number of reports submitted per year:

Wellbutrin Xl, Topamax, Wellbutrin, Suboxone, Celebrex, Wegovy, Lexapro for a 50-year old woman.

Information of the patient in this study:

  • Age: 50
  • Gender: female

What are the drugs?

What are the conditions?

What are the adverse effects?


Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

  • Blood Insulin Decreased:
    - among females aged 50 (±5) who take the same drugs: 0% (0 of 18)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 89)
  • Heart Pounding Or Racing (feelings or sensations that your heart is pounding or racing):
    - among females aged 50 (±5) who take the same drugs: 0% (0 of 18)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 89)

By each condition:

  • people who have Blood Insulin Decreased with Major Depression:
    - among females aged 50 (±5) who have Major Depression: 0% (0 of 3,382)
    - among people who have Major Depression, regardless of gender or age: 0% (0 of 31,832)
  • people who have Blood Insulin Decreased with Lose Weight:
    - among females aged 50 (±5) who have Lose Weight: 0.03% (1 of 3,471)
    - among people who have Lose Weight, regardless of gender or age: 0.03% (7 of 23,430)
  • people who have Blood Insulin Decreased with Generalised Anxiety Disorder:
    - among females aged 50 (±5) who have Generalised Anxiety Disorder: 0% (0 of 1,250)
    - among people who have Generalised Anxiety Disorder, regardless of gender or age: 0% (0 of 13,638)
  • people who have Blood Insulin Decreased with Migraine:
    - among females aged 50 (±5) who have Migraine: 0% (0 of 20,269)
    - among people who have Migraine, regardless of gender or age: 0% (0 of 135,537)
  • people who have Blood Insulin Decreased with Chronic Back Pain:
    - among females aged 50 (±5) who have Chronic Back Pain: 0% (0 of 2)
    - among people who have Chronic Back Pain, regardless of gender or age: 0% (0 of 18)
  • people who have Blood Insulin Decreased with Arthritis:
    - among females aged 50 (±5) who have Arthritis: 0% (0 of 7,171)
    - among people who have Arthritis, regardless of gender or age: 0% (0 of 90,309)
  • people who have Heart Pounding Or Racing with Major Depression:
    - among females aged 50 (±5) who have Major Depression: 1.98% (67 of 3,382)
    - among people who have Major Depression, regardless of gender or age: 1% (319 of 31,832)
  • people who have Heart Pounding Or Racing with Lose Weight:
    - among females aged 50 (±5) who have Lose Weight: 2.07% (72 of 3,471)
    - among people who have Lose Weight, regardless of gender or age: 1.68% (394 of 23,430)
  • people who have Heart Pounding Or Racing with Generalised Anxiety Disorder:
    - among females aged 50 (±5) who have Generalised Anxiety Disorder: 1.84% (23 of 1,250)
    - among people who have Generalised Anxiety Disorder, regardless of gender or age: 2.05% (280 of 13,638)
  • people who have Heart Pounding Or Racing with Migraine:
    - among females aged 50 (±5) who have Migraine: 1.46% (296 of 20,269)
    - among people who have Migraine, regardless of gender or age: 1.19% (1,611 of 135,537)
  • people who have Heart Pounding Or Racing with Chronic Back Pain:
    - among females aged 50 (±5) who have Chronic Back Pain: 0% (0 of 2)
    - among people who have Chronic Back Pain, regardless of gender or age: 0% (0 of 18)
  • people who have Heart Pounding Or Racing with Arthritis:
    - among females aged 50 (±5) who have Arthritis: 1.52% (109 of 7,171)
    - among people who have Arthritis, regardless of gender or age: 0.98% (883 of 90,309)

By each drug (FDA data only):

  • people who take Lexapro and have Blood Insulin Decreased:
    - among females aged 50 (±5) who take Lexapro and have side effects: 0% (0 of 9,722)
    - among people who take Lexapro and have side effects, regardless of gender or age: 0% (1 of 82,253)
  • people who take Wellbutrin Xl and have Blood Insulin Decreased:
    - among females aged 50 (±5) who take Wellbutrin Xl and have side effects: 0% (0 of 2,273)
    - among people who take Wellbutrin Xl and have side effects, regardless of gender or age: 0% (0 of 18,205)
  • people who take Topamax and have Blood Insulin Decreased:
    - among females aged 50 (±5) who take Topamax and have side effects: 0% (0 of 7,625)
    - among people who take Topamax and have side effects, regardless of gender or age: 0% (0 of 54,173)
  • people who take Suboxone and have Blood Insulin Decreased:
    - among females aged 50 (±5) who take Suboxone and have side effects: 0% (0 of 1,565)
    - among people who take Suboxone and have side effects, regardless of gender or age: 0% (0 of 28,312)
  • people who take Celebrex and have Blood Insulin Decreased:
    - among females aged 50 (±5) who take Celebrex and have side effects: 0% (0 of 14,459)
    - among people who take Celebrex and have side effects, regardless of gender or age: 0% (0 of 147,580)
  • people who take Wegovy and have Blood Insulin Decreased:
    - among females aged 50 (±5) who take Wegovy and have side effects: 0% (0 of 560)
    - among people who take Wegovy and have side effects, regardless of gender or age: 0.02% (1 of 4,836)
  • people who take Wellbutrin and have Blood Insulin Decreased:
    - among females aged 50 (±5) who take Wellbutrin and have side effects: 0% (0 of 13,356)
    - among people who take Wellbutrin and have side effects, regardless of gender or age: 0% (1 of 101,604)
  • people who take Suboxone and have Heart Pounding Or Racing:
    - among females aged 50 (±5) who take Suboxone and have side effects: 2.11% (33 of 1,565)
    - among people who take Suboxone and have side effects, regardless of gender or age: 0.7% (197 of 28,312)
  • people who take Celebrex and have Heart Pounding Or Racing:
    - among females aged 50 (±5) who take Celebrex and have side effects: 1.72% (248 of 14,459)
    - among people who take Celebrex and have side effects, regardless of gender or age: 1.04% (1,538 of 147,580)
  • people who take Wegovy and have Heart Pounding Or Racing:
    - among females aged 50 (±5) who take Wegovy and have side effects: 1.96% (11 of 560)
    - among people who take Wegovy and have side effects, regardless of gender or age: 1.03% (50 of 4,836)
  • people who take Wellbutrin and have Heart Pounding Or Racing:
    - among females aged 50 (±5) who take Wellbutrin and have side effects: 1.91% (255 of 13,356)
    - among people who take Wellbutrin and have side effects, regardless of gender or age: 1.21% (1,232 of 101,604)
  • people who take Lexapro and have Heart Pounding Or Racing:
    - among females aged 50 (±5) who take Lexapro and have side effects: 1.94% (189 of 9,722)
    - among people who take Lexapro and have side effects, regardless of gender or age: 1.36% (1,115 of 82,253)
  • people who take Wellbutrin Xl and have Heart Pounding Or Racing:
    - among females aged 50 (±5) who take Wellbutrin Xl and have side effects: 2.29% (52 of 2,273)
    - among people who take Wellbutrin Xl and have side effects, regardless of gender or age: 1.57% (285 of 18,205)
  • people who take Topamax and have Heart Pounding Or Racing:
    - among females aged 50 (±5) who take Topamax and have side effects: 1.27% (97 of 7,625)
    - among people who take Topamax and have side effects, regardless of gender or age: 1.08% (587 of 54,173)

Common drug interactions *:

  1. Back Pain : 6 people, 33.33%
  2. Cervical Spinal Stenosis (narrowing of the spinal canal in the neck): 5 people, 27.78%
  3. General Physical Health Deterioration (weak health status): 5 people, 27.78%
  4. Drug Ineffective : 5 people, 27.78%
  5. Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 5 people, 27.78%
  6. Suicidal Ideation : 5 people, 27.78%
  7. Intervertebral Disc Protrusion (spinal disc protrusion): 5 people, 27.78%
  8. Muscle Aches (muscle pain): 5 people, 27.78%
  9. Borderline Personality Disorder : 4 people, 22.22%
  10. Chronic Kidney Disease : 4 people, 22.22%
  11. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 16.67%
  12. High Blood Pressure : 2 people, 11.11%
  13. Disability : 2 people, 11.11%
  14. Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 11.11%
  15. Osteoporosis (bones weak and more likely to break): 2 people, 11.11%
  16. Clavicle Fracture : 2 people, 11.11%
  17. Diabetes : 2 people, 11.11%
  18. Foot Fracture : 2 people, 11.11%
  19. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
  20. Emotional Disorder : 1 person, 5.56%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 61.11%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 38.89%
  3. Hypersensitivity : 5 people, 27.78%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 27.78%
  5. Insomnia (sleeplessness): 4 people, 22.22%
  6. Infection : 3 people, 16.67%
  7. High Blood Cholesterol : 3 people, 16.67%
  8. Inflammation : 3 people, 16.67%
  9. Bipolar Disorder (mood disorder): 3 people, 16.67%
  10. Diabetes : 2 people, 11.11%
  11. Cough : 2 people, 11.11%
  12. Constipation : 2 people, 11.11%
  13. Headache (pain in head): 2 people, 11.11%
  14. Bone Disorder : 2 people, 11.11%
  15. Hypokalemia (low potassium): 2 people, 11.11%
  16. Immune System Disorder : 2 people, 11.11%
  17. Back Pain : 2 people, 11.11%
  18. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 11.11%
  19. Affective Disorder (mental disorder): 2 people, 11.11%
  20. Sleep Apnea Syndrome : 2 people, 11.11%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

  1. Abilify (12 people, 66.67%)
  2. Lyrica (10 people, 55.56%)
  3. Xyrem (10 people, 55.56%)
  4. Synthroid (10 people, 55.56%)
  5. Valium (10 people, 55.56%)
  6. Savella (9 people, 50.00%)
  7. Depakote (8 people, 44.44%)
  8. Nucynta (8 people, 44.44%)
  9. Zantac (8 people, 44.44%)
  10. Seroquel (8 people, 44.44%)
  11. Amitiza (8 people, 44.44%)
  12. Viibryd (8 people, 44.44%)
  13. Robaxin (7 people, 38.89%)
  14. Dilaudid (7 people, 38.89%)
  15. Elmiron (7 people, 38.89%)
  16. Vivelle-Dot (7 people, 38.89%)
  17. Vagifem (7 people, 38.89%)
  18. Inderal (6 people, 33.33%)
  19. Cymbalta (6 people, 33.33%)
  20. Opana (6 people, 33.33%)

Drug effectiveness *:

Wellbutrin Xl:

n/a

Topamax:

n/a

Wellbutrin:

n/a

Suboxone:

n/a

Celebrex:

n/a

Wegovy:

n/a

Lexapro:

n/a

* Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Treatments, associated medications and conditions:

Drug side effects:

Drug interactions:

Symptoms:

Drugs that are associated with:

Conditions that are associated with:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: